Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 9/20/24 → 9/20/26 |
Funding
- Merck Sharp & Dohme Corporation: $2.00
WCG-25-LUN-115G-MSD-PMC:Substudy 01G: A Phase 2, Umbrella Study With Rolling Arms of Investigational Agents in Combination With Pembrolizumab With or Without Platinum-based Chemotherapy in Treatment-Na?ve Participants With Stage IV Non-small Cell Lung Can
- Arnold, Susanne M (PI)